YAG laser peripheral iridotomy for the prevention of pigment dispersion glaucoma a prospective, randomized, controlled trial.
Scott
Andrew
A
Glaucoma Service, Moorfields Eye Hospital, London, United Kingdom. andy.scott@ucl.ac.uk
Kotecha
Aachal
A
Bunce
Catey
C
Balidis
Miltos
M
Garway-Heath
David F
DF
Miller
Michael H
MH
Wormald
Richard
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000008:administration & dosage; D018450:Disease Progression; D017889:Exfoliation Syndrome / Q000503:physiopathology / Q000517:prevention & control*; D005260:Female; D005901:Glaucoma / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology; D032801:Iridectomy / Q000379:methods*; D007498:Iris / Q000601:surgery*; D053685:Laser Therapy; D053844:Lasers, Solid-State; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000503:physiopathology / Q000517:prevention & control; D011446:Prospective Studies; D014065:Tonometry, Ocular; D055815:Young Adult
D000959:Antihypertensive Agents